If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
30.30    0.20 (0.66%)
Bid:
30.20
Ask:
31.70
Spread: 1.50 (4.967%)
Market Cap: £82.58m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

Biofuels Update

18 Mar 2011 07:06

RNS Number : 1999D
Pursuit Dynamics PLC
18 March 2011
 



18 March 2011

 

Pursuit Dynamics PLC (AIM: PDX)

("PDX" or the "Company')

 

Biofuels update

 

PDX is pleased to announce today that it has agreed to formal terms with Pacific Ethanol Columbia LLC for the commercial operation of the Ethanol Reactor System ("ERS") installation at its Columbia Plant near Boardman, Oregon (USA). The agreement, which is in line with previous guidance, ensures that PDX would share in the full range of benefits that accrue to Pacific Ethanol Columbia through operating the ERS, which we believe will include an enhanced yield, reduced operating cost, reduced enzyme costs and improved cycle times.

 

Commenting on the announcement, Neil Koehler, CEO of Pacific Ethanol, Inc. (NASDAQ CM: PEIX), which manages the plant, stated:

 

"The agreement with PDX enables the continued operation of the ERS and verification of the benefits it delivers at the Pacific Ethanol Columbia plant in Boardman, Oregon. We are pleased to advance our relationship with PDX as it demonstrates our continued focus on introducing new technology that will enable us to enhance the yields on corn ethanol and optimizing the overall performance of our ethanol production plants."

 

Commenting on the announcement, Roel Pieper, CEO of PDX said:

 

"Today's announcement is the culmination of a tremendous amount of hard work on behalf of the team who have worked diligently and tirelessly to demonstrate the ERS's commercial potential. We now look forward to growing the business further and continuing to drive commercial returns."

 

- Ends -

 

For Further Information, please contact:

 

PDX

Roel Pieper, CEO

Tel: +44 (0)1480 422050

Richard Webster, CFO

Financial Dynamics

Ben Foster

Marc Cohen

Tel: +44 (0) 20 7831 3113

Tel: +44 (0) 7802 877 241

 

 

Cenkos Securities

Ian Soanes

Max Hartley

Tel: +44 (0)20 7397 8924

Mirabaud Securities

Rory Scott

Tel: +44 (0) 20 7878 3360

 

 

Notes to Editors

 

About PDX

 

- PDX (AIM: PDX) owns and commercialises the PDX Atomiser and Reactor technologies that enable significant reductions in energy usage, process acceleration and result enhancement for a wide range of industrial processes and applications.

 

- The PDX business model is currently organised into six Lines of Business - Biofuels; Brewing, Food and Beverages; Public Health and Decontamination; Industrial Licensing; Water and New Ventures.

 

- PDX is headquartered in Huntingdon (UK) with an office in London (UK), Schaffhausen (Switzerland) and Connecticut (USA).

 

- Further information is available at the Company's website: www.pdx.biz 

 

- Publication quality photographs are available from FD.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDVLBFFXFBBBE
Date   Source Headline
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20255:25 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20255:21 pmRNSTotal Voting Rights and Share Capital
3rd Nov 20257:00 amRNSTransaction in Own Shares*
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNS-RLicensing agreement extension with Light & Wonder
2nd Oct 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSInterim Results
1st Sep 20255:26 pmRNSNotice of Results
30th Jul 202512:15 pmRNSTotal Voting Rights and Share Capital
30th Jul 202512:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20253:37 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.